Get started
ABEONA THERAPEUTICS INCABEONA THERAPEUTICS INCABEONA THERAPEUTICS INC

ABEONA THERAPEUTICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

PCJ chart

Upcoming earnings

Next report date
Report period
Q1 2024
EPS estimate
−0.48EUR
Revenue estimate
‪154.46 K‬EUR

Key stats

Market capitalization
‪81.35 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.35EUR
Net income (FY)
‪−49.09 M‬EUR
Revenue (FY)
‪3.17 M‬EUR
Shares float
‪25.91 M‬
Beta (1Y)
0.32

About Abeona Therapeutics Inc.

Sector
Health Technology
CEO
Vishwas Seshadri
Headquarters
Cleveland
Website
abeonatherapeutics.com
Employees (FY)
84
Founded
1974
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PCJ is 3.10 EUR — it has increased by 6.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ABEONA THERAPEUTICS INC stocks are traded under the ticker PCJ.
ABEONA THERAPEUTICS INC is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
PCJ stock is 10.34% volatile and has beta coefficient of 0.32. Check out the list of the most volatile stocks — is ABEONA THERAPEUTICS INC there?
PCJ earnings for the last quarter are −0.45 EUR per share, whereas the estimation was −0.50 EUR resulting in a 10.00% surprise. The estimated earnings for the next quarter are −0.43 EUR per share. See more details about ABEONA THERAPEUTICS INC earnings.
Yes, you can track ABEONA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
PCJ stock has fallen by 56.64% compared to the previous week, the month change is a 54.31% fall, over the last year ABEONA THERAPEUTICS INC has showed a 12.43% decrease.
PCJ net income for the last quarter is ‪−15.03 M‬ EUR, while the quarter before that showed ‪−11.20 M‬ EUR of net income which accounts for −34.25% change. Track more ABEONA THERAPEUTICS INC financial stats to get the full picture.
Today ABEONA THERAPEUTICS INC has the market capitalization of ‪83.13 M‬, it has decreased by 5.45% over the last week.
No, PCJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PCJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABEONA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
PCJ reached its all-time high on Mar 7, 2024 with the price of 8.31 EUR, and its all-time low was 2.90 EUR and was reached on Apr 25, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 84.00 employees. See our rating of the largest employees — is ABEONA THERAPEUTICS INC on this list?
We've gathered analysts' opinions on ABEONA THERAPEUTICS INC future price: according to them, PCJ price has a max estimate of 33.56 EUR and a min estimate of 7.46 EUR. Read a more detailed ABEONA THERAPEUTICS INC forecast: see what analysts think of ABEONA THERAPEUTICS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABEONA THERAPEUTICS INC EBITDA is ‪−40.77 M‬ EUR, and current EBITDA margin is ‪−1.29 K‬%. See more stats in ABEONA THERAPEUTICS INC financial statements.